Sanofi top pharmaceuticals revenue change 2020

This statistic shows the change in revenue of Sanofi's top pharmaceuticals in 2020 compared to the previous year. Dupixent, a rare blood disorder drug, showed the highest growth rate among all of Sanofi's best-selling pharmaceutical drugs.

Change in revenue of Sanofi's top pharmaceuticals in 2020 compared to previous year*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2021

Region

Worldwide

Survey time period

2019 and 2020

Supplementary notes

* Change measured on a reported basis.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical biotech industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.